Table 2 PEF analyses as a percentage of personal best PEF
From: Effect of adjusting the combination of budesonide/formoterol on the alleviation of asthma symptoms
Total | Fixed-dose group | Adjusted-dose group | |
|---|---|---|---|
Mean (%) | 89.8 ± 5.6 | 89.3 ± 7.6 | 90.2 ± 3.8 |
CV (standard deviation/mean) | 0.045 ± 0.022 | 0.044 ± 0.022 | 0.047 ± 0.023 |
Minimum/Maximum | 0.74 ± 0.13 | 0.75 ± 0.15 | 0.72 ± 0.12 |
Morning – evening (%) | − 1.03 ± 1.65 | −1.23 ± 1.38 | −0.88 ± 1.86 |
Mean PEF with symptoms (%): | |||
Cough | 87.1 ± 6.8 | 85.4 ± 8.0 | 88.1 ± 6.2 |
Dyspnea | 85.5 ± 7.9 | 82.6 ± 10.9 | 86.8 ± 6.4 |
Wheeze | 83.6 ± 7.7 | 81.8 ± 11.6 | 84.2 ± 6.5 |
Mean PEF in each month (%): | |||
January | 88.5 ± 6.2 | 87.5 ± 8.5 | 89.2 ± 4.3 |
February | 89.0 ± 7.8 | 85.8 ± 11.1 | 90.7 ± 5.3 |
March | 87.9 ± 8.2 | 85.6 ± 11.2 | 89.4 ± 5.6 |
April | 88.9 ± 7.1 | 85.6 ± 10.7 | 90.5 ± 4.0 |
May | 88.8 ± 5.5 | 88.0 ± 7.1 | 89.3 ± 4.5 |
June | 89.5 ± 7.9 | 88.4 ± 10.3 | 90.2 ± 6.5 |
July | 90.3 ± 7.4 | 87.7 ± 10.8 | 92.2 ± 3.1 |
August | 90.5 ± 6.9 | 88.8 ± 10.0 | 91.7 ± 3.7 |
September | 90.8 ± 6.5 | 90.2 ± 9.3 | 91.1 ± 3.8 |
October | 90.1 ± 5.7 | 90.0 ± 7.3 | 90.2 ± 4.5 |
November | 89.2 ± 6.7 | 89.5 ± 8.3 | 89.0 ± 5.6 |
December | 88.3 ± 6.5 | 88.0 ± 8.3 | 88.5 ± 5.2 |